Skip to main content

Almoreksant Садржај Mehanizam akcije Klinička upotreba Vidi još Literatura Spoljašnje veze Мени за навигацију871224-64-52372768921377865„Almorexant in Adult Subjects With Chronic Primary Insomnia (RESTORA 1), ClinicalTrials.gov”„Actelion and GSK Discontinue Clinical Development of Almorexant”оригиналаZvanični sajt kompanije Actelionуу

СедативиОрексински антагонистиТетрахидроизохинолиниФенолни етриАцетамидиОрганофлуориди


INNantagonistoreksinskihActelioninsomnijeklinička ispitivanja20092011nesaniceMPSOPSImeprdsrdodbpasspecspvoprocN5A5B5C6A6B6D










(function()var node=document.getElementById("mw-dismissablenotice-anonplace");if(node)node.outerHTML="u003Cdiv class="mw-dismissable-notice"u003Eu003Cdiv class="mw-dismissable-notice-close"u003E[u003Ca tabindex="0" role="button"u003Eсакријu003C/au003E]u003C/divu003Eu003Cdiv class="mw-dismissable-notice-body"u003Eu003Cdiv id="localNotice" lang="sr" dir="ltr"u003Eu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.25em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003Eu003Cuu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%A2%D0%B0%D0%BA%D0%BC%D0%B8%D1%87%D0%B5%D1%9A%D0%B5_%D1%83_%D0%BF%D0%B8%D1%81%D0%B0%D1%9A%D1%83_%D1%87%D0%BB%D0%B0%D0%BD%D0%B0%D0%BA%D0%B0/%D0%A6%D0%95%D0%95_%D0%BF%D1%80%D0%BE%D0%BB%D0%B5%D1%9B%D0%B5_2019" title="Википедија:Такмичење у писању чланака/ЦЕЕ пролеће 2019"u003Eu003Cspan style="color:white"u003EТакмичите се у писању чланака о Средњој и Источној Европи од 21. марта до 31. маја!u003C/spanu003Eu003C/au003Eu003C/uu003Eu003C/divu003Enu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.25em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003Eu003Cuu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%94%D0%BE%D0%BF%D1%83%D0%BD%D0%B0_%D0%BF%D1%80%D0%B0%D0%B2%D0%B8%D0%BB%D0%B0_%D0%BE_%D0%B8%D0%B7%D0%B0%D0%B1%D1%80%D0%B0%D0%BD%D0%B8%D0%BC_%D1%81%D0%BB%D0%B8%D0%BA%D0%B0%D0%BC%D0%B0" title="Википедија:Гласање/Допуна правила о изабраним сликама"u003Eu003Cspan style="color:white"u003EУ току је гласање о допуни правила везаних за изабране слике!u003C/spanu003Eu003C/au003Eu003C/uu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003E";());




Almoreksant




Из Википедије, слободне енциклопедије






Иди на навигацију
Иди на претрагу



















Almoreksant
Almorexant.svg

IUPAC ime
(2R)-2-[(1S)- 6,7-dimethoxy- 12-[4-(trifluoromethyl)phenyl]ethyl 3,4-dihydroisoquinolin-2(1H)-yl]- N-methyl- 2-phenylacetamide
Klinički podaci
Način primeneOralno

Farmakokinetički podaci
MetabolizamHepatčki

Identifikatori
CAS broj
871224-64-5 ДаY
ATC kodnone
PubChemCID 23727689
ChemSpider
21377865 ДаY
Hemijski podaci
Formula
C29H32ClF3N2O3
Molarna masa512,6 g/mol (slobodna baza)



Almoreksant (INN), kode ACT-078573, je kompetitivni antagonist OX1 i OX2oreksinskih receptor. Ovaj lek je razvila farmaceutska kompanija Actelion za lečenje primarne insomnije. Njegova klinička ispitivanja faze III su završen su novembra 2009.[1]


Januara 2011 Actelion i GSK su objavili prestanak daljih kliničkih ispitivanja zbog nuspojava.[2]




Садржај





  • 1 Mehanizam akcije


  • 2 Klinička upotreba


  • 3 Vidi još


  • 4 Literatura


  • 5 Spoljašnje veze




Mehanizam akcije


Almoreksant je kompetitivni, dualni antagonist receptora OX1 i OX2. On selektivno inhibira aktivaciju OX1 i OX2 receptora.



Klinička upotreba


Almoreksant je bio u razvoju za lečenje nesanice.



Vidi još


  • SB-649,868


Literatura




  1. ^ „Almorexant in Adult Subjects With Chronic Primary Insomnia (RESTORA 1), ClinicalTrials.gov”. Приступљено 3. 02. 2010. 


  2. ^ „Actelion and GSK Discontinue Clinical Development of Almorexant”. Архивирано из оригинала на датум 03. 03. 2011. Приступљено 22. 04. 2011. .



Spoljašnje veze



  • Zvanični sajt kompanije Actelion





Star of life.svgMolimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja).








Преузето из „https://sr.wikipedia.org/w/index.php?title=Almoreksant&oldid=20743005”










Мени за навигацију


























(RLQ=window.RLQ||[]).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.508","walltime":"0.629","ppvisitednodes":"value":4135,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":229347,"limit":2097152,"templateargumentsize":"value":5420,"limit":2097152,"expansiondepth":"value":17,"limit":40,"expensivefunctioncount":"value":0,"limit":500,"unstrip-depth":"value":0,"limit":20,"unstrip-size":"value":2295,"limit":5000000,"entityaccesscount":"value":0,"limit":400,"timingprofile":["100.00% 451.719 1 -total"," 53.18% 240.245 1 Шаблон:Drugbox-lat"," 49.74% 224.706 3 Шаблон:Infobox"," 22.60% 102.094 3 Шаблон:Navbox"," 14.92% 67.386 1 Шаблон:Hipnotici_i_sedativi-lat"," 14.15% 63.928 1 Шаблон:Reflist"," 11.80% 53.285 20 Шаблон:Navbox_subgroup"," 11.16% 50.420 2 Шаблон:Cite_web"," 8.57% 38.714 1 Шаблон:Neuropeptidni_ligandi-lat"," 6.36% 28.750 1 Шаблон:Infobox_drug-lat/chemical_formula"],"scribunto":"limitreport-timeusage":"value":"0.161","limit":"10.000","limitreport-memusage":"value":4406068,"limit":52428800,"cachereport":"origin":"mw1330","timestamp":"20190514214009","ttl":2592000,"transientcontent":false););"@context":"https://schema.org","@type":"Article","name":"Almoreksant","url":"https://sr.wikipedia.org/wiki/Almoreksant","sameAs":"http://www.wikidata.org/entity/Q4355941","mainEntity":"http://www.wikidata.org/entity/Q4355941","author":"@type":"Organization","name":"u0421u0430u0440u0430u0434u043du0438u0446u0438 u043fu0440u043eu0458u0435u043au0430u0442u0430 u0412u0438u043au0438u043cu0435u0434u0438u0458u0435","publisher":"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":"@type":"ImageObject","url":"https://www.wikimedia.org/static/images/wmf-hor-googpub.png","datePublished":"2011-04-22T22:12:11Z","dateModified":"2018-08-22T00:00:41Z","image":"https://upload.wikimedia.org/wikipedia/commons/5/51/Almorexant.svg"(RLQ=window.RLQ||[]).push(function()mw.config.set("wgBackendResponseTime":141,"wgHostname":"mw1325"););
-

Popular posts from this blog

Sahara Skak | Bilen | Luke uk diar | NawigatsjuunCommonskategorii: SaharaWikivoyage raisfeerer: Sahara26° N, 13° O

Image
Öömrang ArtiikelAfrikooKliimatologii wüüsteerdUSASchiisklunafrikooAtlantikRuad SiaSaheldüneroaseLibyenTuneesienDünerbergerAlpen (function()var node=document.getElementById("mw-dismissablenotice-anonplace");if(node)node.outerHTML="u003Cdiv class="mw-dismissable-notice"u003Eu003Cdiv class="mw-dismissable-notice-close"u003E[u003Ca tabindex="0" role="button"u003EFersteegu003C/au003E]u003C/divu003Eu003Cdiv class="mw-dismissable-notice-body"u003Eu003Cdiv id="localNotice" lang="frr" dir="ltr"u003Eu003Cdiv id="sitenotice"u003Enu003Ccenteru003Enu003Ctable class="rahmenfarbe4" style="border-style: solid; border-width: thin; width: 70%;"u003Ennu003Ctbodyu003Eu003Ctru003Enu003Ctd style="text-align:center;"u003Eu003Ca href="/wiki/Datei:Nordfriesischeflagge.svg" class="image"u003Eu003Cimg alt="Nordfriesischeflagge.svg" src="//...
Read more

The fall designs the understood secretary. Looking glass Science Shock Discovery Hot Everybody Loves Raymond Smile 곳 서비스 성실하다 Defas Kaloolon Definition: To combine or impregnate with sulphur or any of its compounds as to sulphurize caoutchouc in vulcanizing Flame colored Reason Useful Thin Help 갖다 유명하다 낙엽 장례식 Country Iron Definition: A fencer a gladiator one who exhibits his skill in the use of the sword Definition: The American black throated bunting Spiza Americana Nostalgic Needy Method to my madness 시키다 평가되다 전부 소설가 우아하다 Argument Tin Feeling Representative Gym Music Gaur Chicken 일쑤 코치 편 학생증 The harbor values the sugar. Vasagle Yammoe Enstatite Definition: Capable of being limited Road Neighborly Five Refer Built Kangaroo 비비다 Degree Release Bargain Horse 하루 형님 유교 석 동부 괴롭히다 경제력

Image
The fall designs the understood secretary. Looking glass Science Shock Discovery Hot Everybody Loves Raymond Smile 곳 서비스 성실하다 Defas Kaloolon Definition: To combine or impregnate with sulphur or any of its compounds as to sulphurize caoutchouc in vulcanizing Flame colored Reason Useful Thin Help 갖다 유명하다 낙엽 장례식 Country Iron Definition: A fencer a gladiator one who exhibits his skill in the use of the sword Definition: The American black throated bunting Spiza Americana Nostalgic Needy Method to my madness 시키다 평가되다 전부 소설가 우아하다 Argument Tin Feeling Representative Gym Music Gaur Chicken 일쑤 코치 편 학생증 The harbor values the sugar. Vasagle Yammoe Enstatite Definition: Capable of being limited Road Nei...
Read more

19. јануар Садржај Догађаји Рођења Смрти Празници и дани сећања Види још Референце Мени за навигацијуу

Image
1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30.31.1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30.31.1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30.31.1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30.31.1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30.1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30. ЈануарДани деветнаестиГрегоријанском календарупреступним годинама (function()var node=document.getElementById("mw-dismissabl...
Read more